Studio Investment Management’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
29,154
-684
-2% -$27.4K 0.21% 73
2026
Q1
$1.08M Sell
29,838
-1,018
-3% -$39K 0.2% 75
2025
Q4
$1.19M Sell
30,856
-657
-2% -$24.7K 0.22% 70
2025
Q3
$1.14M Sell
31,513
-1,395
-4% -$48.7K 0.22% 70
2025
Q2
$1.13M Buy
32,908
+146
+0.4% +$4.63K 0.23% 70
2025
Q1
$1.03M Buy
32,762
+186
+0.6% +$6.07K 0.21% 74
2024
Q4
$1.04M Buy
32,576
+1,140
+4% +$37.1K 0.22% 75
2024
Q3
$1.03M Buy
31,436
+17,974
+134% +$565K 0.22% 80
2024
Q2
$419K Buy
13,462
+1,296
+11% +$38.6K 0.1% 113
2024
Q1
$362K Buy
+12,166
New +$345K 0.09% 123

Other funds holding QLTY

Studio Investment Management's QLTY Position: Q2 2026 in Review

Studio Investment Management reduced its GMO US Quality ETF (QLTY) stake by 2.3% in Q2 2026, selling an estimated $27.4K and leaving 29,154 shares worth $1.22M. The position accounts for 0.21% of the portfolio, ranked #73.

Studio Investment Management first reported a position in QLTY in Q1 2024 and has held it in 10 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Studio Investment Management held 29,154 shares of GMO US Quality ETF worth $1.22M as of Q2 2026.
  • Studio Investment Management sold 684 GMO US Quality ETF shares in Q2 2026, an estimated $27.4K.
  • GMO US Quality ETF made up 0.21% of Studio Investment Management's portfolio in Q2 2026, its #73 holding.
  • Studio Investment Management first reported a position in GMO US Quality ETF in Q1 2024 and has held it in 10 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.